Aurobindo Pharma Eyes Massive Zentiva Buyout, Sees Shares Dip 5% Amid Deal Buzz
Aurobindo Pharma’s shares fell nearly 5% amid reports of a $5 billion Zentiva acquisition. While the deal could boost global…
